Search

everythinglearnresearchcommunity

for

Search:↓

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Lupus can cause hair loss and nail changes, with treatments available for both.

Lupus patients' body image issues significantly affect their mental health and need more support.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

CD2 might be a new treatment target for patchy alopecia areata.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

A woman with lupus had rare severe symptoms but improved with treatment.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

A 28-year-old man with type 1 diabetes had skin and hair issues due to zinc deficiency.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

Anti-CD19 therapy may help treat SLE and NMOSD.

Dental procedures and immunosuppressants can lead to heart infections in lupus patients.